ADLM Calls on Feds to Regulate AI in the Clinical Lab Sector
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
From - G2 Compliance Advisor
It all looked so promising back in 2015. Privately-held Theranos was poised to usher in a new era of diagnostics with its revolutionary fingerprick technology for…
By Mike O'Brien bio
Here is my periodic update prepared for interested HR professionals trying to deal with the complex American employment laws…
From - G2 Compliance Advisor
With the 2018 Clinical Laboratory Fee Schedule (CLFS) still in the works, CMS proposed changes to the Hospital Outpatient Prospective Payment System (HOPPS) rules on…
From - National Intelligence Report
While the strategy of targeting the China market is nothing new, the tactics have evolved. Recognizing the need for a…
From - Laboratory Industry Report
When it comes to measuring Dx product effectiveness, few things speak louder than the attitudes of ordering physicians. With that in mind…
From - National Intelligence Report
Last year at this time, the Justice Department announced the results of a nationwide takedown involving "the most defendants charged and largest alleged loss amount in…
From - Laboratory Industry Report
After a relatively slow March and April, business has picked up noticeably in May, June and July with deal volume increasing across all…
From - G2 Compliance Advisor
The way you handle an OSHA inspection can have as much impact on the outcome as the actual health and safety condition of your lab. More precisely…